R&D Changing Faces: Board appointments, November and December 20... As 2025 came to a close, we also saw a modest number of Board appointments, on both advisory and governance Boards.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires – Q4... The healthcare services ecosystem has seen significant leadership movement in recent months.
Digital Changing Faces: Digital and supplier hires, November and Dec... November and December saw a number of interesting hires in the wider life sciences sphere, spanning digital health innovations and R&D.
R&D Changing Faces: Pharma and biotech hires, November and Decem... In our final batch of Changing Faces columns from 2025, we’re detailing a flurry of senior leadership appointments in recent months.
R&D Changing Faces – Board of Directors and Advisory Boards - Oc... From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.
Digital Changing Faces – Digital and supplier hires - October 2025 In the digital and supplier space, we saw a good deal of personnel movement in October, including a number of CEO appointments.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
